International Business Advisory board

Adrian Bradley
Partner and Patent Attorney at Cleveland IP

Adrian Bradley is a Partner and Chartered Patent Attorney at Cleveland IP, the London-based intellectual property firm.

He trained as a patent attorney in the pharmaceutical industry and has worked extensively on Supplementary Protection Certificates and advises on regulatory data exclusivity.

Adrian particularly enjoys working with universities to assist them in commercialising their technology. He is a visiting lecturer at the University of Reading, and has developed a business game to help academics understand the commercial potential of their research.

Adrian is a regular speaker on patent-related matters and delivered a TEDx Talk at the National Technical Library, Prague, in February 2016, the video can be found here.


Dr. John Normanton
Managing Director Oxandia Limited UK

John is a neuropharmacologist by training, having pursued an academic career in the Department of Physiology at the University of Oxford before pursuing a varied career in clinical research with Sandoz (now Novartis), venture capital (with a 3i subsidiary) and technology transfer (Imperial Innovations, Imperial College London).

He co-founded an oncology company (Sterix Limited) in 1998 as a joint spin out from Imperial College and the University of Bath raising £8M in syndicated VC funding, negotiating multi-£million partnerships and out-licences and completing a Phase I clinical trial for the company’s lead product. The company gave rise to numerous successful lead optimization programmes in oncology, women’s health and diabesity and was subsequently acquired by The Ipsen Group with several of Sterix’s drug candidates ultimately entering clinical development (19 clinical trials to date with two compounds currently in Phase II).

Dr. Normanton worked with Ipsen, including as Director of Commercial Project Planning, and has broad experience in clinical development, venture funding, technology transfer, strategic IP management, business development and early stage university spin-out management.  Since then, he has provided consultancy advice to academia, start-ups and pharma via his consultancy companies, Oxandia Limited and ArgantriX Limited.

He is now ‘launch’ CEO for a number of collaborative university spin-outs (from the Universities of Oxford, Cambridge, Swansea & Bath and the Karolinska Institutet) operating across multiple clinical areas including oncology, antimicrobials and neurodegeneration.


Vit Perlik MD, PhD
Director of Regulatory and Clinical Development at Pharminvent

Vit is currently acting as a Director of Regulatory Science and Clinical Development in Pharminvent.

He is profoundly skilled in the area of Clinical Development strategies/study design/data mining, which he gained in multinational pharmaceutical companies e.g. Sanofi, Zentiva Inhalationprodukte and Zentiva. His background includes over 15 years of research experience covering areas of clinical pharmacology and phase I as well as phase II and III studies particularly in inhalation drug development, generic development and pain and obesity management.

Educated at the 3rd faculty of medicine in Charles University and resident at the Bulovka hospital department of infectious disease, Vit also served a three years tenure as a Postdoctoral Research Fellow at the Health Science Center, University of Tennessee in the US.

As a professional, Vit had facilitated the design, strategic development and data mining of bioequivalence, pharmacodynamics and clinical studies.  As a member of the PharmInvent team he is responsible for driving the processes for clinical development strategy including but not limited to scientific support, protocol development, scientific evaluation and data interpretation.


Jiri Michal, Ing

Jiri Michal is a highly experienced professional of the pharmaceutical industry. He has been with Zentiva for 36 years and served as its CEO from 1993-2010.





Trademark and Design Attorney & IP Lawyer at INVENTIA s.r.o.

Born in Prague, Ingrid obtained her first professional education at the Dance Conservatoire in Prague and became a ballet dancer of the National Theatre Ballet in Prague. Later on, motivated by numerous stories of dancers who were notably disadvantaged due to lack of knowledge of own rights and duties, and inspired by her father who is an attorney-at-law, she decided to pursue a new career in law.

At the BA Hons. Comparative Law program of the University of Wales she studied law from both continental and Anglo-Saxon legal perspective and got orientated in international and cross-border legal matters. During her LL.M. degree in Rotterdam, which was focused on Commercial Law, she realized that her favorite field of law was and still is Intellectual Property Law.

After her studies, she returned to Prague and begun to work as a Junior Lawyer in a medium-size law firm with general legal practice. One year later, she joined INVENTIA s.r.o. – a patent attorney and licensing advisory company. Since then she is fully focused on Intellectual Property Law.

Her practice at INVENTIA s.r.o. consists of Trademark and Design Attorney work, representing clients in proceedings before the Czech Intellectual Property Office, European Union Intellectual Property Office and International Bureau of the World Intellectual Property Organization. Ingrid also provides advisory services in the field of licensing of intellectual property, transfer of technologies and other legal aspects of intellectual property.